Sort
82,697 grants matching “vaccine development”
Human Dendritic Cells and In Vivo Immunity to Biothreat
$3,124,596Baylor Research Institute · U19 · FY2005 · AI
CHEMOKINE ADJUVANTS FOR BIOTHREAT PATHOGEN VACCINES
$3,124,002Maureen Howard · Chemocentryx, Inc. · U19 · FY2007 · AI
COVID-19 Epidemiology and Immune-Pathogenesis in Pregnant Women, Mothers and Children
$3,123,720Mary A Staat · Cincinnati Childrens Hosp Med Ctr · U01 · FY2021 · AI
SPORE in Prostate Cancer
$3,122,009Baylor College Of Medicine · P50 · FY2002 · CA
Protective Mechanisms Against Pandemic Respiratory Virus
$3,121,975Stanford University · U19 · FY2005 · AI
Maternal Immunization and Determinants of Infant Immunity
$3,121,843Marcela F Pasetti · University Of Maryland Baltimore · U19 · FY2022 · AI
UCSD Department of Medicine HIV/AIDS Clinical Trials Unit
$3,121,542Constance Ann Benson · University Of California, San Diego · U01 · FY2008 · AI
Protective immunity following dengue virus natural infections and vaccination
$3,121,080Eva Harris · University Of California Berkeley · P01 · FY2025 · AI
Task 9/C23 Mouse Models for Influenza
$3,120,565Judy Britt · Southern Research Institute · N01 · FY2009 · AI
Research on the Epidemiology,Prevention,Vaccine Effectiveness and Treatment of Influenza and Other Respiratory Viruses in South Africa.09
$3,120,562Cheryl Cohen · National Health Laboratory Service · U01 · FY2017 · IP
MBRS-SCORE PROGRAM AT UPR, MEDICAL SCIENCES CAMPUS
$3,120,162University Of Puerto Rico Med Sciences · S06 · FY2003 · GM
Enhancing Chimeric Antigen Receptor T Cell Therapies for HematologicMalignancies: Beyond CART 19
$3,119,164Carl H. June · University Of Pennsylvania · P01 · FY2024 · CA
Vaccine Induced Immunity in the Young and Aged
$3,118,287Rafi Ahmed · Emory University · U19 · FY2011 · AI
The Immunobiology of Marrow Allografts for Leukemia
$3,117,289Richard J O'Reilly · Sloan-Kettering Inst Can Research · P01 · FY2010 · CA
Shared Resource Management
$3,115,740M. Celeste Simon · University Of Pennsylvania · P30 · FY2024 · CA
Influenza and Emerging Infectious Diseases
$3,113,196Richard Davey · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Immunobiology of Peanut Allergy and Its Treatment: A Prototype
$3,112,428Hugh Sampson · Icahn School Of Medicine At Mount Sinai · U19 · FY2009 · AI
Case Clinical Trials Unit
$3,112,121Jeffrey M Jacobson · Case Western Reserve University · UM1 · FY2020 · AI
Maternal Immunization and Determinants of Infant Immunity
$3,111,452Marcela F Pasetti · University Of Maryland Baltimore · U19 · FY2023 · AI
Reagent Resource Support Program for AIDS Vaccine Development
$3,110,282Valerie Fremont · Quality Biological, Inc. · N01 · FY2022 · AI
Randomized Trial of High-Dose Rifampin in Patients with New Smear-Positive TB
$3,109,945Carole D Mitnick · Harvard Medical School · U01 · FY2011 · AI
Influenza and Emerging Infectious Diseases
$3,109,509Richard Davey · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Biodefense and Emerging Infectious Disease Vaccine Studies
$3,109,113Lesia Dropulic · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Cleaved, stabilized HIV-1 Env trimers for structural and vaccine studies
$3,108,766John P Moore · Weill Medical Coll Of Cornell Univ · P01 · FY2020 · AI
Clinical Evaluation of Novel Adenovirus Prime-Boost HIV-1 Vaccine
$3,105,484Raphael Dolin · Beth Israel Deaconess Medical Center · U19 · FY2010 · AI